{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:52:31Z","timestamp":1791460351583,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Diabetes Metab Disord"],"DOI":"10.1007\/s40200-026-02083-3","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:08:00Z","timestamp":1791457680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends and projected burden of ischemic heart disease mortality with co-documented diabetes mellitus and dyslipidemia among U.S. adults, 1999\u20132024: a CDC WONDER analysis"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6144-7175","authenticated-orcid":false,"given":"Mehmood","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6670-0411","authenticated-orcid":false,"given":"Muhammad Hammad","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6534-7704","authenticated-orcid":false,"given":"Abdur","family":"Rafey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8443-6650","authenticated-orcid":false,"given":"Mohsin","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6636-0117","authenticated-orcid":false,"given":"Taha","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4452-6652","authenticated-orcid":false,"given":"Mian Zain","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2083_CR1","unstructured":"National Academies Press (US). Ischemic heart disease. Cardiovascular Disability - NCBI Bookshelf. Published 2010. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK209964\/"},{"issue":"1","key":"2083_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05022-x","volume":"25","author":"L Yang","year":"2025","unstructured":"Yang L, Zheng B, Gong Y. Global, regional and national burden of ischemic heart disease and its attributable risk factors from 1990 to 2021: a systematic analysis of the Global Burden of Disease study 2021. BMC Cardiovasc Disord. 2025;25(1):625. https:\/\/doi.org\/10.1186\/s12872-025-05022-x.","journal-title":"BMC Cardiovasc Disord"},{"key":"2083_CR3","unstructured":"Centers for Disease Control and Prevention. Heart disease facts. CDC. Updated October 24, 2024. Accessed August 23. 2026. https:\/\/www.cdc.gov\/heart-disease\/data-research\/facts-stats\/index.html"},{"key":"2083_CR4","unstructured":"Sapra A, Bhandari P. Diabetes. In: StatPearls. StatPearls Publishing; 2026. Accessed August 25, 2026. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551501\/"},{"key":"2083_CR5","unstructured":"Hill MF, Bordoni B. Hyperlipidemia. In: StatPearls. StatPearls Publishing; 2026. Accessed August 25, 2026. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559182\/"},{"issue":"2","key":"2083_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/1574887114666190328125153","volume":"14","author":"A Bisciglia","year":"2019","unstructured":"Bisciglia A, Pasceri V, Irini D, Varveri A, Speciale G. Risk factors for ischemic heart disease. RRCT. 2019;14(2):86\u201394. https:\/\/doi.org\/10.2174\/1574887114666190328125153.","journal-title":"RRCT"},{"issue":"1","key":"2083_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2019","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019;41(1):111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"issue":"8","key":"2083_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/nejm197402212900805","volume":"290","author":"ACA Carvalho","year":"1974","unstructured":"Carvalho ACA, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med. 1974;290(8):434\u20138. https:\/\/doi.org\/10.1056\/nejm197402212900805.","journal-title":"N Engl J Med"},{"issue":"32","key":"2083_CR9","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehx144.","journal-title":"Eur Heart J"},{"issue":"9626","key":"2083_CR10","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/s0140-6736(08)60768-0","volume":"371","author":"T Mazzone","year":"2008","unstructured":"Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet. 2008;371(9626):1800\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(08)60768-0.","journal-title":"Lancet"},{"issue":"8","key":"2083_CR11","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","volume":"57","author":"SaE Peters","year":"2014","unstructured":"Peters SaE, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542\u201351. https:\/\/doi.org\/10.1007\/s00125-014-3260-6.","journal-title":"Diabetologia"},{"issue":"1","key":"2083_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12944-018-0676-x","volume":"17","author":"D Fan","year":"2018","unstructured":"Fan D, Li L, Li Z, et al. Effect of hyperlipidemia on the incidence of cardio-cerebrovascular events in patients with type 2 diabetes. Lipids Health Dis. 2018;17(1):102. https:\/\/doi.org\/10.1186\/s12944-018-0676-x.","journal-title":"Lipids Health Dis"},{"issue":"13","key":"2083_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.122.028896","volume":"12","author":"H Bashar","year":"2023","unstructured":"Bashar H, Kobo O, Khunti K, et al. Impact of the COVID-19 pandemic on diabetes\u2010related cardiovascular mortality in the United States. J Am Heart Assoc. 2023;12(13):e028896. https:\/\/doi.org\/10.1161\/jaha.122.028896.","journal-title":"J Am Heart Assoc"},{"key":"2083_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcrp.2025.200416","volume":"25","author":"MA Naveed","year":"1999","unstructured":"Naveed MA, Neppala S, Chigurupati HD, et al. Trends in coronary artery disease mortality among hyperlipidemic patients: geographic, gender, and racial insights from CDC WONDER data (1999\u20132020). Int J Cardiol Cardiovasc Risk Prev. 1999;25:200416. https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200416.","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"25 Suppl 2","key":"2083_CR15","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2013","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;129(25 Suppl 2):S1-45. https:\/\/doi.org\/10.1161\/01.cir.0000437738.63853.7a.","journal-title":"Circulation"},{"key":"2083_CR16","doi-asserted-by":"publisher","first-page":"108155892614488","DOI":"10.1177\/10815589261448845","volume":"28","author":"A Shubietah","year":"2026","unstructured":"Shubietah A, Bdair M, Zahran A, et al. Temporal trends and disparities in acute ischemic event mortality among U.S. adults with coexisting atherosclerotic heart disease and diabetes mellitus: A national analysis. J Invest Med Published online April. 2026;28:10815589261448845. https:\/\/doi.org\/10.1177\/10815589261448845.","journal-title":"J Invest Med Published online April"},{"issue":"1","key":"2083_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s44197-026-00535-w","volume":"16","author":"F Ahmed","year":"2026","unstructured":"Ahmed F, Abdullah M, Tahir HB, et al. National mortality trends, disparities, and forecasted burden of atrial fibrillation and heart failure with underlying ischemic heart disease among older adults in the united states, 1999\u20132023. J Epidemiol Glob Health. 2026;16(1):47. https:\/\/doi.org\/10.1007\/s44197-026-00535-w.","journal-title":"J Epidemiol Glob Health"},{"key":"2083_CR18","unstructured":"CDC WONDER [Internet]. [cited 2026 Jun 20]. Available from: https:\/\/wonder.cdc.gov\/"},{"issue":"7624","key":"2083_CR19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD.","journal-title":"BMJ"},{"key":"2083_CR20","unstructured":"Multiple Cause of Death. 1999\u20132020 Request [Internet]. [cited 2026 Jun 20]. Available from: https:\/\/wonder.cdc.gov\/mcd-icd10.html"},{"key":"2083_CR21","unstructured":"Multiple Cause of Death. 2018\u20132024, Single Race Request [Internet]. [cited 2026 Sep 12]. Available from: https:\/\/wonder.cdc.gov\/mcd-icd10-expanded.html"},{"key":"2083_CR22","doi-asserted-by":"crossref","unstructured":"Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Hyattsville (MD): National Center for Health Statistics (US); 2001 Jan. 10 p. Report No.: 20. (Healthy People 2010 Statistical Notes).","DOI":"10.1037\/e583772012-001"},{"key":"2083_CR23","unstructured":"Joinpoint Regression Program [Internet]. [cited 2026 Jun 20]. Available from: https:\/\/surveillance.cancer.gov\/joinpoint\/index.html"},{"key":"2083_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2026.116825","volume":"254","author":"A Alyahya","year":"1999","unstructured":"Alyahya A, Albegamy Y, Albalawi MA, et al. Trends in mortality from high-risk surgical procedures: national burden of transplants, implants, and organ removal from 1999 to 2024 in United States. Am J Surg. 1999;254:116825. https:\/\/doi.org\/10.1016\/j.amjsurg.2026.116825.","journal-title":"Am J Surg"},{"issue":"11","key":"2083_CR25","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1097\/MS9.0000000000002629","volume":"86","author":"A Haseeb","year":"1999","unstructured":"Haseeb A, Nasrullah RMU, Siddiq MA, et al. Trends in malignant neoplasm of bone and articular cartilage related mortality among older adults in United States (1999\u20132020). Ann Med Surg. 1999;86(11):6645\u201352. https:\/\/doi.org\/10.1097\/MS9.0000000000002629.","journal-title":"Ann Med Surg"},{"issue":"1","key":"2083_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05036-5","volume":"25","author":"S Rani","year":"1999","unstructured":"Rani S, Kumar L, Ali SME, Ashraf S, Bhimani S, Kumar S, et al. Trends in United States mortality among patients with atrial fibrillation\/flutter related heart failure (1999\u20132024): disparities by gender, race\/ethnicity and region. BMC Cardiovasc Disord. 1999;25(1):558.","journal-title":"BMC Cardiovasc Disord"},{"issue":"6","key":"2083_CR27","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s11255-025-04924-1","volume":"58","author":"L Kumar","year":"1999","unstructured":"Kumar L, Mustafa I, Kumar N, Fasih A, Warisha S, Khan L, et al. Temporal trends in mortality attributable to atrial fibrillation among adults with acute renal failure in the United States, 1999\u20132024. Int Urol Nephrol. 1999;58(6):2269\u201381.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2083_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-026-06989-8","volume":"26","author":"T Ali","year":"2026","unstructured":"Ali T, Kumar L, Iqbal F, Rizvi SHA, Naveed Uz Zafar MA, Ahmed M, et al. Temporal patterns in diabetes and sepsis mortality in older Americans: a population-based analysis. BMC Geriatr. 2026;26(1):236.","journal-title":"BMC Geriatr"},{"issue":"Suppl 1","key":"2083_CR29","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.2337\/dc25-S010","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular disease and risk management: standards of care in diabetes\u20142025. Diabetes Care. 2025;48(Suppl 1):S207\u201338. https:\/\/doi.org\/10.2337\/dc25-S010.","journal-title":"Diabetes Care"},{"issue":"10","key":"2083_CR30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","volume":"9","author":"N Sattar","year":"2021","unstructured":"Sattar N, Lee MMY, Kristensen SL, et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials. Lancet Diabetes Endocrinol. 2021;9(10):653\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(21)00203-5.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2083_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108921","volume":"177","author":"A Tsapas","year":"2021","unstructured":"Tsapas A, Karagiannis T, Avgerinos I, et al. GLP-1 receptor agonists for cardiovascular outcomes with and without metformin: a systematic review and meta-analysis of cardiovascular outcomes trials. Diabetes Res Clin Pract. 2021;177:108921. https:\/\/doi.org\/10.1016\/j.diabres.2021.108921.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2083_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","volume":"6","author":"MA Bethel","year":"2018","unstructured":"Bethel MA, Patel RA, Merrill P, et al. Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis. Lancet Diabetes Endocrinol. 2018;6(2):105\u201313. https:\/\/doi.org\/10.1016\/S2213-8587(17)30412-6.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2083_CR33","doi-asserted-by":"publisher","first-page":"204201882312217","DOI":"10.1177\/20420188231221740","volume":"14","author":"M Evans","year":"2023","unstructured":"Evans M, Kuodi P, Akunna CJ, et al. Cardiovascular and renal outcomes of GLP-1 receptor agonists vs DPP-4 inhibitors and basal insulin in type 2 diabetes mellitus: a systematic review and meta-analysis. Ther Adv Endocrinol Metab. 2023;14:20420188231221740. https:\/\/doi.org\/10.1177\/20420188231221740.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2083_CR34","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s10741-020-09954-8","volume":"26","author":"T T\u00e4ger","year":"2020","unstructured":"T\u00e4ger T, Atar D, Agewall S, et al. Comparative efficacy of sodium-glucose cotransporter-2 inhibitors for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Heart Fail Rev. 2020;26:1421\u201335. https:\/\/doi.org\/10.1007\/s10741-020-09954-8.","journal-title":"Heart Fail Rev"},{"key":"2083_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/dom.71128","author":"GA Silverii","year":"2026","unstructured":"Silverii GA, et al. Effect of medications for type 2 diabetes on cardiovascular events and mortality: a comprehensive pairwise and network meta-analysis. Diabetes Obes Metab. 2026. https:\/\/doi.org\/10.1111\/dom.71128.","journal-title":"Diabetes Obes Metab"},{"key":"2083_CR36","doi-asserted-by":"publisher","unstructured":"Kilickap M et al. GLP-1 receptor agonists and SGLT-2 inhibitors in patients with versus without cardiovascular disease: a systematic review, meta-analysis, and trial sequential analysis. 2023. https:\/\/doi.org\/10.1007\/s10741-023-10308-9","DOI":"10.1007\/s10741-023-10308-9"},{"issue":"1","key":"2083_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jacc.2024.09.1215","volume":"85","author":"LX Marinacci","year":"2025","unstructured":"Marinacci LX, Zheng Z, Mein S, Wadhera RK. Rural-urban differences in cardiovascular mortality in the United States, 2010\u20132022. J Am Coll Cardiol. 2025;85(1):93\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2024.09.1215.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2083_CR38","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1161\/CIR.0000000000001256","volume":"150","author":"KE Joynt Maddox","year":"2024","unstructured":"Joynt Maddox KE, Elkind MSV, Aparicio HJ, et al. Forecasting the burden of cardiovascular disease and stroke in the United States through 2050\u2014prevalence of risk factors and disease: a presidential advisory from the American Heart Association. Circulation. 2024;150(4):e65\u201388. https:\/\/doi.org\/10.1161\/CIR.0000000000001256.","journal-title":"Circulation"},{"issue":"2","key":"2083_CR39","doi-asserted-by":"publisher","first-page":"e231047","DOI":"10.1001\/jamanetworkopen.2023.1047","volume":"6","author":"CJ Brown","year":"2023","unstructured":"Brown CJ, Chang LS, Hosomura N, et al. Assessment of sex disparities in nonacceptance of statin therapy and low-density lipoprotein cholesterol levels among patients at high cardiovascular risk. JAMA Netw Open. 2023;6(2):e231047. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.1047.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2083_CR40","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1001\/jamacardio.2023.0228","volume":"8","author":"JA Jacobs","year":"2023","unstructured":"Jacobs JA, Addo DK, Zheutlin AR, et al. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US. JAMA Cardiol. 2023;8(5):443\u201352. https:\/\/doi.org\/10.1001\/jamacardio.2023.0228.","journal-title":"JAMA Cardiol"},{"issue":"8","key":"2083_CR41","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.numecd.2018.03.012","volume":"28","author":"V Bittner","year":"2018","unstructured":"Bittner V, et al. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men. Nutr Metab Cardiovasc Dis. 2018;28(8):810\u20135. https:\/\/doi.org\/10.1016\/j.numecd.2018.03.012.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"2083_CR42","doi-asserted-by":"publisher","first-page":"e029850","DOI":"10.1161\/JAHA.122.029850","volume":"13","author":"HR Reynolds","year":"2024","unstructured":"Reynolds HR, et al. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial. J Am Heart Assoc. 2024;13(5):e029850. https:\/\/doi.org\/10.1161\/JAHA.122.029850.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"2083_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027716","volume":"12","author":"M Ashraf","year":"2023","unstructured":"Ashraf M, Jan MF, Bajwa TK, et al. Sex disparities in diagnostic evaluation and revascularization in patients with acute myocardial infarction\u2014a 15-year nationwide study. J Am Heart Assoc. 2023;12(6):e027716. https:\/\/doi.org\/10.1161\/JAHA.122.027716.","journal-title":"J Am Heart Assoc"},{"key":"2083_CR44","doi-asserted-by":"publisher","first-page":"101547","DOI":"10.1016\/j.ijcha.2024.101547","volume":"55","author":"AE Spiering","year":"2024","unstructured":"Spiering AE, van Ommen AMLN, van Roeters JE, et al. Underrepresentation of women in cardiovascular disease clinical trials\u2014What\u2019s in a Name? IJC Heart Vasc. 2024;55:101547. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101547.","journal-title":"IJC Heart Vasc"},{"key":"2083_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2024-324625","author":"U Tayal","year":"2024","unstructured":"Tayal U, Pompei G, Wilkinson I, et al. Advancing the access to cardiovascular diagnosis and treatment among women with cardiovascular disease: a joint British Cardiovascular Societies\u2019 consensus document. Heart. 2024. https:\/\/doi.org\/10.1136\/heartjnl-2024-324625.","journal-title":"Heart"},{"issue":"5","key":"2083_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S2213-8587(16)00052-8","volume":"4","author":"JHY Wu","year":"2016","unstructured":"Wu JHY, Foote C, Blomster J, et al. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2016;4(5):411\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(16)00052-8.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2083_CR47","doi-asserted-by":"publisher","first-page":"1462705","DOI":"10.3389\/fcvm.2025.1462705","volume":"12","author":"H Yang","year":"2025","unstructured":"Yang H, Ma Q, Han L, Liu H. A global prediction of cardiovascular disease from 2020 to 2030. Front Cardiovasc Med. 2025;12:1462705. https:\/\/doi.org\/10.3389\/fcvm.2025.1462705 . PMID: 40860359; PMCID: PMC12375611.","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"2083_CR48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7326\/M23-0720","volume":"176","author":"DA Frank","year":"2023","unstructured":"Frank DA, Johnson AE, Hausmann LRM, et al. Disparities in Guideline-Recommended Statin Use for Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and Gender. Ann Intern Med. 2023;176(8):1057\u201366. https:\/\/doi.org\/10.7326\/M23-0720.","journal-title":"Ann Intern Med"},{"issue":"18","key":"2083_CR49","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1001\/jama.2020.2047","volume":"323","author":"SH Cross","year":"2020","unstructured":"Cross SH, Mehra MR, Bhatt DL, Nasir K, O\u2019Donnell CJ, Califf RM, Warraich HJ. Rural-Urban Differences in Cardiovascular Mortality in the US, 1999\u20132017. JAMA. 2020;323(18):1852\u20134. https:\/\/doi.org\/10.1001\/jama.2020.2047.","journal-title":"JAMA"},{"issue":"4","key":"2083_CR50","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.amepre.2010.12.019","volume":"40","author":"LE Barker","year":"2011","unstructured":"Barker LE, Kirtland KA, Gregg EW, Geiss LS, Thompson TJ. Geographic distribution of diagnosed diabetes in the U.S.: a diabetes belt. Am J Prev Med. 2011;40(4):434\u20139. https:\/\/doi.org\/10.1016\/j.amepre.2010.12.019.","journal-title":"Am J Prev Med"},{"key":"2083_CR51","doi-asserted-by":"publisher","unstructured":"Ahmed M, Hasan M, Kumar S, Ahmed S, Zafar MNU, Kumar L, et al. Trends and forecast of heart failure-related deaths in US chronic obstructive pulmonary disease patients (1999\u20132030): insights from advanced time-series modeling. Cardiol Rev. 2025. https:\/\/doi.org\/10.1097\/CRD.0000000000001083 . Epub ahead of print.","DOI":"10.1097\/CRD.0000000000001083"},{"issue":"2","key":"2083_CR52","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1097\/MS9.0000000000004729","volume":"88","author":"A Mahmood","year":"2026","unstructured":"Mahmood A, Latif F, Latif S, Smith DN, Ayalew BD, Raja A, et al. Heart failure and tobacco use disorder: mortality trends and disparities in the United States. Ann Med Surg (Lond). 2026;88(2):1639\u201347.","journal-title":"Ann Med Surg (Lond)"},{"issue":"10","key":"2083_CR53","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1007\/s11255-025-04490-6","volume":"57","author":"L Kumar","year":"1999","unstructured":"Kumar L, Ali T, Iqbal F, Ahmed M, Azeem B. Unveiling trends in urinary tract cancer mortality among older adults in the United States (1999\u20132022): a CDC WONDER perspective. Int Urol Nephrol. 1999;57(10):3151\u201361.","journal-title":"Int Urol Nephrol"},{"issue":"39","key":"2083_CR54","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043\u2013140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192.","journal-title":"Eur Heart J"}],"container-title":["Journal of Diabetes & Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40200-026-02083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40200-026-02083-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40200-026-02083-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:08:03Z","timestamp":1791457683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40200-026-02083-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2083"],"URL":"https:\/\/doi.org\/10.1007\/s40200-026-02083-3","relation":{},"ISSN":["2251-6581"],"issn-type":[{"value":"2251-6581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"4 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Artificial intelligence (AI) tools, specifically OpenAI\u2019s ChatGPT (GPT-4), were used to assist in the drafting and editing of this manuscript. These tools were employed solely to support language refinement, grammar correction, and structural clarity. No AI-generated content was used to replace or simulate original intellectual contributions, data interpretation, critical analysis, or conceptual development. All substantive content reflects the authors' own work and interpretation. The authors have reviewed and verified all AI-assisted text to ensure accuracy and integrity in accordance with the journal\u2019s authorship and ethical standards.","order":2,"name":"Ethics","label":"Artificial intelligence generated content","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final version of the manuscript. They took complete responsibility for the data\u2019s integrity and the data analysis\u2019s accuracy.","order":3,"name":"Ethics","label":"Guarantor statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Authors, affirm that this manuscript is an honest, accurate, and transparent account of the study being reported, that no important aspects of the study have been omitted, and that any discrepancies from the study as planned (and if relevant, registered) have been explained.","order":4,"name":"Ethics","label":"Transparency statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"285"}}